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Abstract
Background: Acute myocardial infarction (AMI) is, in most cases, caused by a sudden
closure of the coronary artery by a clot. Elevated levels of plasmin-a2-antiplasmin (PAP)
complexes and D-dimers indicate active coagulation and fibrinolysis, which is secondary to
coagulation. The purpose of the study was to evaluate the processes of coagulation and plasma
fibrinolysis by measuring the concentrations of PAP complexes and D-dimers in AMI patients
before starting fibrinolytic and anticoagulant treatment.
Material and methods: 70 patients with ST-elevation AMI were enrolled in the study. The
mean age of the patients was 54.2 ± 7.7 years. The control group consisted of 25 healthy
subjects selected according to age and sex.
Results: In the AMI group the concentrations of both PAP complexes and D-dimers were
significantly higher (p < 0.0001) than in the control group. A highly significant positive
correlation (r = 0.52; p < 0.0001) was found between concentrations of PAP complexes and
D-dimers. Positive correlations were established between concentrations of D-dimers and
fibrinogen (r = 0.29; p < 0.02) and between concentrations of D-dimers and patient age (r = 0.27;
p < 0.05). A negative correlation was identified between the concentration of PAP complexes
and body mass index (r = –0.24; p < 0.05).
Conclusions: The significantly higher concentration of PAP complexes and its close correla-
tion with D-dimers indicate a considerable activation of plasminogenesis in the AMI patient
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group and support the theory of fibrinolysis secondary to coagulation. The data constitute
further evidence in support of the fundamental role of both systems in the pathogenesis of
myocardial infarction. (Folia Cardiol. 2005; 12: 370–376)
PAP complexes, D-dimers, myocardial infarction
Introduction
Acute myocardial infarction (AMI) is, in near-
ly all cases, caused by a sudden closure of the coro-
nary artery by a clot formed on the atheromatous
plaque, destabilised because of ulceration, dissec-
tion or rupture [1]. The ruptured plaque comes into
contact with blood flow and triggers the clot forma-
tion on its surface, which can completely close the
artery lumen. Many authors have regarded disor-
ders in this system as an important risk factor in
the development of ischaemic heart disease and
atherosclerosis, with its grave complications [2, 3].
On the basis of angiography, de Wood et al. [4] dia-
gnosed total closure of the coronary vessel by the
clot in 87% of AMI patients with Q-wave myocar-
dial infarction (QMI) within 6 hours of the onset of
symptoms. In non-Q-wave myocardial infarction
total artery closure within 24 hours was observed
in 26% of patients. Other authors [5], in autopsy
examinations, found the clot in the coronary vessel
in 74% of patients who died of myocardial infarc-
tion within 6 hours of the onset of symptoms.
The mechanism of vessel closure in acute co-
ronary episodes, particularly unstable angina pec-
toris and myocardial infarction, is similar. This in-
dicates the importance of haemostasis disorders not
only in the pathogenesis of the onset and progres-
sion of atherosclerosis, but also in acute complica-
tions of this disease [6].
The plasmin generation may be investigated
directly by examining the formation process or in-
directly by assessing the results of its action on
fibrinogen and fibrin. The amount of plasmin formed
is assessed by means of the concentration of pla-
smin-a2-antiplasmin complex (PAP). An elevation
of PAP-complex concentrations is found in diseases
such as ischaemic heart disease, diabetes mellitus,
in patients after surgery and in neoplasmatic dise-
ases [7–10]. Plasmin, acting on meshed fibrin, forms
fragments of varying sizes, the smallest of which
are D-dimers. An elevated concentration of
D-dimers may reflect activation of both coagulation
and fibrinolysis, which is secondary to coagulation.
Several authors have examined PAP comple-
xes and D-dimers in hypercoagulable states
[11–14], but only a few have determined the con-
centration of specific haemostatic markers before
fibrinolytic or anticoagulant treatment in AMI [15, 16].
Tataru et al. [13] identified higher concentrations
of D-dimers in patients with more advanced arte-
riosclerosis. This supported the hypothesis that the
concentration of D-dimers is dependent on the
amount of fibrin in clots present in atheromatous
plaques. In contrast, Bayes-Genis et al. [12] analy-
sed concentrations of PAP complexes and D-dimers
in patients with unstable angina following myocar-
dial infarction, de novo unstable angina pectoris and
unstable angina with progressive symptoms. All the
patients had increased concentrations of PAP com-
plexes and D-dimers in comparison to the control
group consisting of healthy subjects. The highest
increase in PAP complex concentration was found
in the group with post-infarction angina pectoris, the
reason for which was claimed to be the type of clot
found in angiography in acute myocardial infarction.
The clot contained considerable fibrin, whereas
clots in two other types of unstable angina pectoris
consisted mainly of platelets. The results of this
study strengthened the hypothesis that thrombus
plays a crucial role in the development of acute co-
ronary episodes.
The aim of our study was to evaluate the co-
agulation and plasma fibrinolysis processes by me-
asuring both PAP-complex and D-dimer concentra-
tions in AMI patients before essential treatment.
Material and methods
70 patients with ST elevation AMI, 56 men and
14 women, aged between 37 and 67 years (mean
54.2 ± 7.7 years) were enrolled in the study. The
diagnosis of AMI was based on a typical history,
changes in electrocardiograms and evidence of hi-
gher levels of troponin I and fraction CK-MB. The
period between the onset of myocardial infarction
symptoms and blood sampling was 6 hours on ave-
rage. The following were excluded from the study:
patients over 70 years of age, those admitted to
hospital with cardiogenic shock or after resuscita-
tion, patients diagnosed with diabetes mellitus,
neoplastic disease or chronic diseases that could
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affect the body’s homeostasis, patients with hyper-
lipidaemia treated pharmacologically and patients
taking oral anticoagulants. The control group con-
sisted of 25 healthy subjects selected according to
sex and age: women with a negative history of ischa-
emic heart disease and men with a negative history
and negative results from a cardiological exercise test
on a moving track according to Bruce’s protocol.
Blood for examination was sampled from pa-
tients, their written consent having previously been
obtained, immediately after admission to hospital
and diagnosis of acute myocardial infarction and
before essential treatment (fibrinolytic/anticoagu-
lant or invasive), although an initial dose of oral
aspirin (325 mg) had been administered as part of
the immediate first aid. Some patients required
administration of sublingual glyceryl trinitrate or
intravenous morphine. The blood was sampled from
the veins of the cubital area at minimal venostasis
and placed in a plastic tube containing 3.2% sodium
citrate with a blood:citrate ratio of 9:1. The blood
sample was placed in a centrifuge and rotated at 4oC
for 20 minutes at 3,000 rotations per minute. The
low platelet plasma obtained was portioned and fro-
zen at –70oC until examination. Blood sampling in
the control group was conducted in the morning
(between 7 and 9 a.m.), after 30 minutes’ rest.
The concentration of plasmin-a2-antiplasmin
complexes was measured with the Enzygnost PAP
test produced by Behring Marburg (normal range:
120–700 ng/ml). D-dimer concentration was measu-
red with BioMerieux VIDA apparatus and the im-
munoenzymatic method with a fluorescent reading
(normal range: 70–500 ng/ml). PAP and D-dimers
were measured using the immunoenzymatic me-
thod ELISA (Enzyme Linked Immunosorbent
Assay). Fibrynogen concentration was measured
with the Hemolab Fibrinomat test produced by Bio-
Merieux (normal range 2.0–4.0 g/l). The body mass
index (BMI) was calculated for each patient, defi-
ned as the ratio of body mass in kg to height in square
meters: BMI = b.m./height2.
Statistical analysis
In the statistical analysis for the various tests,
the values of basic statistics were determined, such
as mean value, standard deviation, parametric in-
dex of changeability, minimal value in test and ma-
ximum value in test. Because of a significant asym-
metry in some tests, median, low and high quarti-
les were additionally calculated. Verification of the
compatibility hypothesis was performed using the
Shapiro-Wilks and classic c2-Pearson tests. For the
parameters not derived from a population with
a normal distribution, the Mann-Whitney U test was
carried out to compare two tests. When parametric
tests were used, the classic Student’s T test was
applied to compare tests. When the variance equ-
ality hypothesis was rejected, the parametric test
was used to compare two means, according to
Welch’s version. The correlation index of Spear-
man’s range was determined for the parameters stu-
died. The results were drawn up using Microsoft®
Access 2.0 for Windows and StatSoft® Statistica 5.0 for
Windows. The informed consent of each patient was
obtained. The Regional Ethics Committee of Medical
University, Bydgoszcz gave its assent to the study.
Results
A comparison of the examined parameters of
the fibrinolysis system between the AMI patient
and control groups is shown in Table 1.
In AMI patients a highly significant positive cor-
relation (r = 0.52; p < 0.0001) was found between
D-dimer concentrations and PAP complexes (Fig. 1).
Positive correlations were observed between the
concentration of D-dimer and fibrinogen (r = 0.29;
p < 0.02) and between the concentration of D-dimer
and patient age (r = 0.27; p < 0.05) (Fig. 2, 3).
Table 1. The comparison of concentrations of PAP complexes and D-dimers between patients with
acute myocardial infarction and the control group
Tabela 1. Porównanie stężenia kompleksów PAP i D-dimerów u chorych z zawałem serca i pacjentami
z grupy kontrolnej
Myocardial infarction Control group         p
x ± SD Median Low High x ± SD Median Low High
 quartile  quartile  quartile quartile
PAP [ng/ml] 871 ± 788 705 388 1007 259 ± 131 218 189 285 0,0001
D-dimers [ng/ml] 594 ± 983 354 254 513 223 ± 109 210 136 303 0,0001
Parameter
[unit]
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A significant negative correlation was found
between the concentration of PAP complexes and
BMI (r = –0.24; p < 0.05) (Fig. 4).
Discussion
Rigorous selection was enforced in our studies
of coagulation and plasma fibrinolysis systems. This
enabled us to qualify to the study patients diagno-
sed with ischaemic heart disease without any of the
disorders that could influence the fibrinolysis sys-
tem parameters. The evaluation of concentrations
of PAP complexes and D-dimers during the early
hours of myocardial infarction was not dependent
on the influence of fibrinolytic drugs and anticoagu-
lants on haemostasis, thus enabling us to present
its state at the moment of the onset of acute myo-
cardial infarction. The reliability of the measure-
ments of the plasma fibrinolysis system parameters
was increased by the relatively large number of
groups of patients enrolled in the study.
The results of our study showed considerably
elevated concentrations of PAP complexes and
D-dimers in patients with acute myocardial infarc-
tion. This indicates the intensified process of pla-
sma fibrinolysis in an early phase of myocardial in-
farction as a defence reaction of the organism to co-
agulation activation and clot formation in the
coronary arteries. These data are consistent with
the results obtained by other authors [15, 16].
Similar results were reported by Bayes-Genis et al.
[12] in patients with unstable angina.
The concentrations of these parameters did not
influence the clinical treatment of myocardial infarc-
Figure 1. Correlation between D-dimer concentration
and PAP complexes in patients with acute myocardial
infarction
Rycina 1. Korelacja stężenia D-dimerów i kompleksów
PAP u chorych z zawałem serca
Figure 2. Correlation between D-dimer concentration and
fibrinogen in patients with acute myocardial infarction
Rycina 2. Korelacja stężenia D-dimerów i fibrynogenu
u chorych z zawałem serca
Figure 4. Correlation between concentration of PAP
complexes and body mass index in patients with acute
myocardial infarction
Rycina 4. Korelacja stężenia kompleksów PAP i wskaź-
nika masy ciała u chorych z zawałem serca
Figure 3. Correlation between D-dimer concentration
and the age of patients with acute myocardial infarction
Rycina 3. Korelacja stężenia D-dimerów i wieku u cho-
rych z zawałem serca
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tion in our patients. Nevertheless, as other authors
also report, the usefulness of measuring PAP-complex
and D-dimer concentrations would appear to have im-
portant implications for follow-up studies on ischemic
heart disease in this group of patients [17, 18]. Accor-
ding to Cushman et al. [19] and Sakkinen et al. [20],
elevated concentrations of PAP complexes and
D-dimers may indicate subclinical atherosclerosis in pa-
tients over 65 years of age and make it possible to pre-
dict myocardial infarction in these patients in future.
In our studies, we found a highly positive cor-
relation between concentrations of PAP complexes
and D-dimers. The correlation confirms the rela-
tionship between these parameters, as published by
Lopez et al. [11], Bayes-Genis et al. [12] and Sak-
kinen et al. [20], and shows the legitimacy of the cho-
ice of these parameters to evaluate the activity of
both fibrinolysis and coagulation systems. D-dimer
concentration was also positively correlated with the
concentration of fibrinogen. This supports the hypo-
thesis of other authors that D-dimer concentration
depends on the amount of fibrin in clots in atherosc-
lerotic lesions [13]. The positive correlation between
D-dimers and patient age is consistent with data
presented by other authors [11, 21]. D-dimer con-
centration increases with age and may be an indica-
tor of more advanced atherosclerosis. This correla-
tion was confirmed by the elevated level of D-dimers
in people with spreading atherosclerotic lesions [19].
A negative correlation was established in our
studies between PAP complexes and BMI. This
suggests weaker plasminogenesis in patients with
a higher BMI. A similar relationship was observed
by Sakkinen et al. [20] in her studies. Moreover,
she also showed negative correlations between PAP
complexes and other components of the insulin-
resistant syndrome, PAI-1 antigen and insulin.
On the basis of prospective studies, it is known
that people with low basic fibrinolytic plasma acti-
vity (linked with a high concentration and low acti-
vity of t-PA antigen), are more often exposed to
later myocardial infarction than patients with a low
concentration of antigen and high t-PA activity
[19, 22, 23]. If the endogenous method of fibrinoly-
sis activation by t-PA in patients with myocardial
infarction is malfunctioning, as other authors report
[17, 24], the activation may be triggered by plasmi-
nogen activation with kallikrein and factor XII. Re-
gardless of the means of plasma fibrinolysis activa-
tion, the lytic action of this system in patients with
myocardial infarction is insufficient, though Verheu-
ght et al. [18] observed that the clot may in some
cases undergo spontaneous lysis. The development
of myocardial infarction indicates the advantage of
the coagulation process; the clearly increased fibri-
nolytic plasma activity, the body’s defence reaction,
is not sufficient to dissolve the clot obstructing the
lumen of the coronary artery.
Our studies, conducted with the use of modern
laboratory methods of measuring concentrations of
PAP complexes and D-dimers, confirm the funda-
mental role of systems, coagulation and fibrinoly-
sis, in the pathogenesis of myocardial infarction.
Conclusions
1. High concentrations of PAP complexes indicate
considerable plasminogenesis activation in an
early phase of myocardial infarction.
2. A significantly increased D-dimer concentra-
tion and a high positive correlation between
this and PAP complexes indicate activation of
coagulation and plasma fibrinolysis.
3. Age and an increased BMI might be factors
which influence the balance between the co-
agulation and plasma fibrinolysis systems in
AMI patients.
4. Follow-up studies on the same group of pa-
tients is required for assessment of the progno-
stic value for the further course of ischaemic
heart disease of measuring PAP-complex and
D-dimer concentrations in AMI patients.
Streszczenie
Wstęp: Ostry zawał serca jest spowodowany nagłym zamknięciem światła tętnicy wieńcowej
przez skrzeplinę. Powstaniu skrzepliny może sprzyjać względna przewaga układu krzepnięcia
nad układem fibrynolizy osoczowej. W momencie powstania skrzepliny dochodzi do wtórnej
aktywacji procesu fibrynolizy osoczowej. Kompleksy PAP powstają w wyniku reakcji plazminy
i a2-antyplazminy i są czułym i powszechnie uznanym wskaźnikiem plazminogenezy in vivo.
D-dimery są najmniejszymi fragmentami powstającymi w wyniku działania plazminy na
usieciowaną fibrynę, a ich podwyższone stężenie świadczy zarówno o aktywacji krzepnięcia,
jak i wtórnej do krzepnięcia aktywacji fibrynolizy. Celem pracy była ocena procesu krzepnięcia
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i fibrynolizy osoczowej poprzez oznaczenie stężenia kompleksów PAP i D-dimerów w surowicy
pacjentów z ostrym zawałem serca z uniesieniem odcinka ST przed zastosowaniem leczenia
zasadniczego.
Materiał i metody: Badaniom poddano 70 chorych (56 mężczyzn, 14 kobiet) z ostrym
zawałem serca. Średnia wieku badanych wynosiła 54,2 ± 7,7 roku. Grupę kontrolną stanowiło
25 osób zdrowych, dobranych pod względem płci i wieku.
Wyniki: W grupie chorych z ostrym zawałem serca stwierdzono znamiennie wyższe (p < 0,0001)
stężenie kompleksów PAP, istotnie wyższe (p < 0,0001) stężenie D-dimerów oraz wysoką
dodatnią korelację (r = 0,52; p < 0,0001) pomiędzy stężeniem kompleksów PAP i D-dimerów.
Wnioski: Znamiennie wyższe stężenie kompleksów PAP wskazuje na znaczną aktywację
plazminogenezy w grupie chorych z ostrym zawałem serca, zaś istotnie wyższe stężenie
D-dimerów i ich wysoka dodatnia korelacja z kompleksami PAP przemawia za wyraźną
aktywacją krzepnięcia i wtórną do wykrzepiania aktywacją procesu fibrynolizy osoczowej.
Dane te są kolejnym dowodem potwierdzającym zasadnicze znaczenie obydwu układów
w patogenezie zawału serca. (Folia Cardiol. 2005; 12: 370–376)
kompleksy PAP, D-dimery, zawał serca
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